Rajiv Gandhi Cancer Institute and Research Centre

Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) is one of North India's premier dedicated cancer hospitals, located in Rohini, New Delhi. Established in 1996 under the Sri Ram Charitable Society, RGCIRC was developed with a mission of providing comprehensive, affordable cancer care to the broad population of North India, where access to specialized oncology services was historically limited. Over nearly three decades, RGCIRC has grown into a comprehensive cancer center with over 300 beds dedicated exclusively to cancer care. The hospital serves patients from Delhi, Haryana, Uttar Pradesh, Rajasthan, Himachal Pradesh, and internationally from South Asian and neighboring countries. RGCIRC combines clinical oncology — surgical, medical, and radiation — with cancer research, education, and prevention programs, establishing itself as an academic and clinical oncology institution. The center manages all types of cancers across adults and children, with dedicated multidisciplinary tumor boards reviewing complex cases to determine optimal treatment strategies. Its NABH accreditation reflects its commitment to patient safety and quality standards.

Rajiv Gandhi Cancer Institute and Research Centre offers comprehensive cancer care across all major oncological disciplines. Surgical Oncology provides cancer surgery across all organ systems — head and neck cancer surgery, thoracic oncological surgery (lung, oesophagus, mediastinum), breast surgery (mastectomy, breast conservation, oncoplastic reconstruction), abdominal cancer surgery (stomach, colorectal, pancreatic, liver, gallbladder), urological cancer surgery (kidney, bladder, prostate), gynaecological cancer surgery (cervix, uterus, ovaries), and bone and soft tissue tumor resection. Medical Oncology delivers chemotherapy, targeted therapy, immunotherapy (checkpoint inhibitors), hormonal therapy, and manages supportive and palliative care. Radiation Oncology uses advanced radiotherapy technology including IMRT (intensity-modulated radiotherapy), IGRT (image-guided radiotherapy), stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS/Gamma Knife equivalent), and brachytherapy. Bone Marrow Transplant (BMT) covers allogeneic and autologous stem cell transplantation for blood cancers (leukemia, lymphoma, myeloma). Paediatric Oncology manages childhood cancers. Palliative Care and Pain Management support quality of life.

RGCIRC in Rohini, New Delhi, maintains facilities specifically designed for comprehensive cancer care. The hospital operates 300+ inpatient beds dedicated to oncology patients. Surgical theatres include dedicated laminar flow operating rooms for cancer surgery across all anatomical regions. Radiation oncology department uses linear accelerators (LINAC) with IMRT, IGRT, VMAT, stereotactic radiosurgery, and brachytherapy. PET-CT scanning enables whole-body cancer staging and treatment response assessment. MRI and CT scan provide detailed anatomical imaging for treatment planning. Bone Marrow Transplant unit maintains a bone marrow infusion facility, sterile rooms, HEPA filtration, and specialist nursing for transplant patients. A dedicated BMT laboratory handles stem cell processing. The clinical laboratory provides comprehensive haematology, biochemistry, tumour markers, flow cytometry, histopathology, cytology, and immunohistochemistry for cancer diagnosis. Oncology pharmacy manages chemotherapy preparation under strict safety protocols. Palliative care and pain management team serve inpatients and outpatients. Cancer registry and research department support clinical research.

Rajiv Gandhi Cancer Institute and Research Centre is an increasingly sought destination for international cancer patients — particularly from Bangladesh, Nepal, Afghanistan, Pakistan, East African nations, and Middle Eastern countries — seeking world-class cancer care at a fraction of the cost available in Western countries. RGCIRC's concentration of oncology expertise in a dedicated cancer centre means patients benefit from multidisciplinary tumor board reviews, consistent surgical oncology expertise, and a full suite of radiation and medical oncology services. Cost of cancer surgery, chemotherapy, and radiotherapy at RGCIRC is typically 60-80% lower than comparable treatment in the UK, USA, or Germany. New Delhi's Rohini location is accessible via Delhi Metro (Red Line — Rohini East station) and road transport from Indira Gandhi International Airport (approximately 30-40 minutes). International patient services coordinate appointment scheduling, medical visa invitation letters, accommodation guidance, and treatment cost estimation. English-speaking oncologists and patient coordinators facilitate communication.

Rajiv Gandhi Cancer Institute and Research Centre holds NABH (National Accreditation Board for Hospitals and Healthcare Providers) accreditation, India's premier hospital quality certification. NABH accreditation is awarded following stringent assessment of patient care standards, clinical governance, medication management, infection control, and hospital management systems. As a cancer research institute, RGCIRC also participates in nationally and internationally recognized cancer research programs, clinical trials, and academic collaborations. The hospital's cancer registry is registered with the Indian Council of Medical Research (ICMR), reflecting its commitment to cancer epidemiology and outcomes data. Radiation oncology quality is assessed through the Atomic Energy Regulatory Board (AERB) which licenses and inspects radiation therapy facilities in India. Patients can verify RGCIRC's current NABH accreditation status through the official NABH online registry. The hospital's Sri Ram Charitable Society trust structure supports its mission of accessible cancer care.